Documents (8) JSON TSV

source DB	source ID	text	size	updated at	# proj.	# Ann.	updated_at
PMC	7205724	Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppr	29.5 KB	2020-12-29	40	537	2021-01-19
PMC	7199903	Site-specific glycan analysis of the SARS-CoV-2 spike SARS-CoV-2 spike protein, elaborated Vaccine	17.9 KB	2020-09-27	39	264	2021-01-19
PMC	7441788	Advances in the use of chloroquine and hydroxychloroquine for the treatment of COVID-19 J. SUN ET AL	42.1 KB	2020-09-27	37	730	2021-01-19
PMC	7253482	Vulnerabilities in coronavirus glycan shields despite extensive glycosylation Abstract Severe acute	37 KB	2020-09-27	37	519	2021-01-19
PMC	7228307	Harnessing the immune system via FcγR function in immune therapy: a pathway to next‐gen mAbs FcγR an	60.9 KB	2020-09-27	37	600	2021-01-19
PMC	7361216	A sugar‐coated strategy to treat a rare neurologic disease provides a blueprint for a decoy glycan t	9.26 KB	2020-11-19	36	131	2021-01-19
PMC	7556165	ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives Abstract Angiotensin-converting	77 KB	2020-12-29	28	1,082	2021-01-19
PMC	7443692	Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor Abstract The S	72.3 KB	2020-12-29	22	0	-